MicroRNA-148a facilitates inflammatory dendritic cell differentiation and autoimmunity by targeting MAFB

Yao Meng(Shanghai Jiao Tong University), Nan Shen(China-Japan Friendship Hospital)

JCI Insight

March 26, 2020

10.1172/jci.insight.133721

Cited by 30

Related Papers

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

|Nature Medicine|2016|570

Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus

|Nature Communications|2019|122

Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications

|Nature Communications|2022|112

SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression

|Nature Communications|2021|69

Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis

|Frontiers in Immunology|2019|65